Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2020

01-12-2020 | Addiction | Perspective

The Importance of Learning Health Systems in Addressing the Opioid Crisis

Authors: Wilson M. Compton, MD, MPE, Tisha Wiley, PhD, Carlos Blanco, MD, PhD

Published in: Journal of General Internal Medicine | Special Issue 3/2020

Login to get access

Abstract

Interventions and research to address the US opioid crisis have, for the most part, targeted opioid use, misuse, and addiction specifically. While such a focus can lead to useful innovations in the care of opioid use disorder, the fact that many persons with opioid use disorder use multiple substances (both over their life course and simultaneously in drug-using episodes) makes it imperative to address broader issues of addiction in persons who have opioid use disorder as their presenting concern. Because of integrated care and the ability to target multiple clinical concerns in parallel, the Veterans Administration (VA) may be uniquely situated to address the key issue of multi-morbidity that persons with opioid use disorder so frequently exhibit. Research at the VA can build on new interventions developed by the National Institutes of Health (and others) and can help to determine the best ways to implement these interventions. Research at the VA does not need to duplicate efforts supported by other funders but can complement such work by providing an integrated platform for determining the best approaches to implementing innovations. The real-world learning health system that has been developed in the VA is poised to contribute in just such important ways.
Literature
1.
go back to reference Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2018. NCHS Data Brief, no 356. Hyattsville, MD: National Center for Health Statistics. 2020. Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2018. NCHS Data Brief, no 356. Hyattsville, MD: National Center for Health Statistics. 2020.
2.
go back to reference Case A, Deaton A. Mortality and morbidity in the 21st century. Brook Pap Econ Act 2017;397-476. Case A, Deaton A. Mortality and morbidity in the 21st century. Brook Pap Econ Act 2017;397-476.
3.
go back to reference Dowell D, Arias E, Kochanek K, Anderson R, Guy GP, Losby J, et al. Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015. JAMA 2017;318(11):1065-1067.CrossRef Dowell D, Arias E, Kochanek K, Anderson R, Guy GP, Losby J, et al. Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015. JAMA 2017;318(11):1065-1067.CrossRef
4.
go back to reference Cranston K, Alpren C, John B, Dawson E, Roosevelt K, Burrage A, et al. Notes from the field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015-2018. Morb Mortal Wkly Rep 2019;68(10):253-254.CrossRef Cranston K, Alpren C, John B, Dawson E, Roosevelt K, Burrage A, et al. Notes from the field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015-2018. Morb Mortal Wkly Rep 2019;68(10):253-254.CrossRef
5.
go back to reference Compton WM, Jones CM. Epidemiology of the U.S. opioid crisis: the importance of the vector. Ann N Y Acad Sci 2019;1451(1):130-143.CrossRef Compton WM, Jones CM. Epidemiology of the U.S. opioid crisis: the importance of the vector. Ann N Y Acad Sci 2019;1451(1):130-143.CrossRef
6.
go back to reference Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence syndrome — 28 States, 1999–2013. MMWR 2016;65:799–802.PubMed Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence syndrome — 28 States, 1999–2013. MMWR 2016;65:799–802.PubMed
7.
go back to reference Zibbell JE, Asher AK, Patel RC, Kupronis, Iqbal BK, Ward JW, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175-181.CrossRef Zibbell JE, Asher AK, Patel RC, Kupronis, Iqbal BK, Ward JW, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175-181.CrossRef
8.
go back to reference Jackson KA, Bohm MK, Brooks JT, Asher A, Nadle J, Bamberg, et al. See I. Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs - six sites, 2005-2016. MMWR 2018;67(22):625-628.PubMed Jackson KA, Bohm MK, Brooks JT, Asher A, Nadle J, Bamberg, et al. See I. Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs - six sites, 2005-2016. MMWR 2018;67(22):625-628.PubMed
10.
go back to reference Jones CM, Campopiano M, Baldwin G, McCance-Katz EF. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health 2015;105(8):55-63.CrossRef Jones CM, Campopiano M, Baldwin G, McCance-Katz EF. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health 2015;105(8):55-63.CrossRef
11.
go back to reference Jones CM, McCance-Katz EF. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Addiction 2019;114(3):471-482.CrossRef Jones CM, McCance-Katz EF. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Addiction 2019;114(3):471-482.CrossRef
12.
go back to reference National Academies of Science, Engineering, and Medicine. 2019. Medications for Opioid Use Disorder Save Lives. Washington, DC: National Academies Press. National Academies of Science, Engineering, and Medicine. 2019. Medications for Opioid Use Disorder Save Lives. Washington, DC: National Academies Press.
14.
go back to reference Compton WM, Wargo EM. Prescription drug monitoring programs: promising practices in need of refinement. Ann Intern Med 2018;168:826–827.CrossRef Compton WM, Wargo EM. Prescription drug monitoring programs: promising practices in need of refinement. Ann Intern Med 2018;168:826–827.CrossRef
15.
go back to reference Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR 2016;65(1):1-49.CrossRef Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR 2016;65(1):1-49.CrossRef
16.
go back to reference Jones CM, Lurie PG, Compton WM. Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013. Am J Public Health 2016;106(4):689-690.CrossRef Jones CM, Lurie PG, Compton WM. Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013. Am J Public Health 2016;106(4):689-690.CrossRef
17.
go back to reference Walley AY, Green TC. Mainstreaming naloxone through coprescription to patients receiving long-term opioid therapy for chronic pain. Ann Intern Med 2016;165(4):292-293.CrossRef Walley AY, Green TC. Mainstreaming naloxone through coprescription to patients receiving long-term opioid therapy for chronic pain. Ann Intern Med 2016;165(4):292-293.CrossRef
18.
go back to reference Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013. MMWR 2015;64(48):1137-1141. Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013. MMWR 2015;64(48):1137-1141.
19.
go back to reference MacArthur GJ, Van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Intl J Drug Policy 2014;25(1):34-52.CrossRef MacArthur GJ, Van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Intl J Drug Policy 2014;25(1):34-52.CrossRef
21.
go back to reference Collins FS, Koroshetz WJ, Volkow ND. Helping to end addiction over the long-term: the research plan for the NIH HEAL Initiative. JAMA 2018;320(2):129–130.CrossRef Collins FS, Koroshetz WJ, Volkow ND. Helping to end addiction over the long-term: the research plan for the NIH HEAL Initiative. JAMA 2018;320(2):129–130.CrossRef
22.
go back to reference Han B, Compton WM, Blanco C, Jones CM. Correlates of prescription opioid use, misuse, use disorders, and motivations for misuse among US adults. J Clin Psychiatry. 2018;79(5):17m11973. Han B, Compton WM, Blanco C, Jones CM. Correlates of prescription opioid use, misuse, use disorders, and motivations for misuse among US adults. J Clin Psychiatry. 2018;79(5):17m11973.
23.
go back to reference Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users — United States, 2002–2013. MMWR Morb Mortal Wkly Rep. 2015; 64(26):719–725.PubMedPubMedCentral Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users — United States, 2002–2013. MMWR Morb Mortal Wkly Rep. 2015; 64(26):719–725.PubMedPubMedCentral
24.
go back to reference Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med. 2015;49(4):493-501.CrossRef Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med. 2015;49(4):493-501.CrossRef
25.
go back to reference Jones CM, Einstein E, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA. 2018;319(17):1819-1821.CrossRef Jones CM, Einstein E, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA. 2018;319(17):1819-1821.CrossRef
26.
go back to reference Namiki M, Mori T, Sawaguchi T, Ito S, Suzuki T. Underlying mechanism of combined effect of methamphetamine and morphine on lethality in mice and therapeutic potential of cooling. J Pharmacol Sci. 2005;99(2):168-176CrossRef Namiki M, Mori T, Sawaguchi T, Ito S, Suzuki T. Underlying mechanism of combined effect of methamphetamine and morphine on lethality in mice and therapeutic potential of cooling. J Pharmacol Sci. 2005;99(2):168-176CrossRef
27.
go back to reference Petry NM, DePhilippis D, Rash CJ, Drapkin M, McKay JR. Nationwide dissemination of contingency management: the Veterans Administration initiative. Am J Addict. 2014;23(3):205–210CrossRef Petry NM, DePhilippis D, Rash CJ, Drapkin M, McKay JR. Nationwide dissemination of contingency management: the Veterans Administration initiative. Am J Addict. 2014;23(3):205–210CrossRef
28.
go back to reference Petry NM. Contingency management treatments: controversies and challenges. Addiction. 2010 Sep; 105(9): 1507–1509CrossRef Petry NM. Contingency management treatments: controversies and challenges. Addiction. 2010 Sep; 105(9): 1507–1509CrossRef
29.
go back to reference Ronsley C, Nolan S, Knight R, Hayashi K, Klimas J, Walley A, Wood E, Fairbairn N. Treatment of stimulant use disorder: a systematic review of reviews. PLoS One. 2020;15(6):e0234809. Ronsley C, Nolan S, Knight R, Hayashi K, Klimas J, Walley A, Wood E, Fairbairn N. Treatment of stimulant use disorder: a systematic review of reviews. PLoS One. 2020;15(6):e0234809.
30.
go back to reference Atkins D, Kilbourne AM, Shulkin D. Moving from discovery to system-wide change: the role of research in a learning health care system: experience from three decades of health systems research in the Veterans Health Administration. Annu. Rev. Public Health 2017;38:467–87 Atkins D, Kilbourne AM, Shulkin D. Moving from discovery to system-wide change: the role of research in a learning health care system: experience from three decades of health systems research in the Veterans Health Administration. Annu. Rev. Public Health 2017;38:467–87
31.
33.
go back to reference Finlay, A. K., Owens, M. D., Taylor, E., Nash, A., Capdarest-Arest, N., Rosenthal, J., ... & Timko, C. (2019). A scoping review of military veterans involved in the criminal justice system and their health and healthcare. Health & justice, 7(1), 6. Finlay, A. K., Owens, M. D., Taylor, E., Nash, A., Capdarest-Arest, N., Rosenthal, J., ... & Timko, C. (2019). A scoping review of military veterans involved in the criminal justice system and their health and healthcare. Health & justice, 7(1), 6.
34.
go back to reference Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, et al. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016;160:222-6. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, et al. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016;160:222-6.
Metadata
Title
The Importance of Learning Health Systems in Addressing the Opioid Crisis
Authors
Wilson M. Compton, MD, MPE
Tisha Wiley, PhD
Carlos Blanco, MD, PhD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue Special Issue 3/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06267-2

Other articles of this Special Issue 3/2020

Journal of General Internal Medicine 3/2020 Go to the issue